Painkiller Ibuprofen Can Slow Down Ageing Process by Fighting Arthritis

by Sasikala Radhakrishnan on June 25, 2014 at 2:32 PM
 Painkiller Ibuprofen Can Slow Down Ageing Process by Fighting Arthritis

Ibuprofen, one of the most popular painkillers, can now be used to slow down ageing process and death by combating arthritis, a new UK study claims.

Scientists have succeeded in unveiling a strong biological link that exists between chronic inflammation caused by an over-active immune system, accelerated ageing and associated diseases, and shortened lifespan.


They also discovered that the widely used over-the-counter painkiller ibuprofen could act as a simple and cheap antidote against the toxic effects of chronic inflammation.

In a series of experiments conducted on inflammation-prone mice that were genetically engineered to age fast, researchers discovered that ibuprofen served the dual purpose of suppressing the animals' inflammation, as well as restoring their ageing rate to normal levels.

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used daily by millions of people around the world to treat headaches, muscle aches, sprains and flu symptoms.

While trying to figure out the association between inflammation and ageing, scientists found that inflammation emitted oxygen-free radicals, which are destructive reactive molecules, which in turn caused damage to DNA and telomeres which function as protective "caps" on chromosomes.

Telomere loss led to a state of arrested growth and normal functioning of cells, also known as "senescence" which is believed to cause ageing. Greater senescence led to further generation of free radicals, creating a vicious cycle.

Scientists found that NSAIDs such as ibuprofen and anti-oxidants, can resist the accumulation of senescent cells.

Diana Jurk, one of the scientists, said: "The most important result of the study is that treatment with a simple and cheap anti-inflammatory drug, ibuprofen, could reverse the progression of cell senescence and restore the ability of tissues to regenerate."

The scientists are now focusing on human patients, including a group of around 200 people with Parkinson's disease, also affected by accelerated ageing.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Drug News

Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
Anti-cancer Drug Navitoclax Help Treat Lower Back Pain
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Painkiller Ibuprofen Can Slow Down Ageing Process by Fighting Arthritis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests